AVH 7.33% $2.53 avita medical inc.

Ann: AVITA Medical to Announce First Quarter 2024 Results, page-74

  1. 365 Posts.
    lightbulb Created with Sketch. 131
    agreed there would be cases like this a kit here and there ordered with a time lag - but we aren’t talking about a small decline in sales aren’t we? comparing to the prior quarter sales dropped a whooping $3m. It is surprising to see that a single product company unable to:

    1. detect the change in a timely manner (before quarterly reporting), and
    2. properly explain to investors key drivers

    its not like they’ve got a complex portfolio of products making it hard to explain overall dynamics

    there’s definitely an opportunity for them to learn from mistakes and hopefully quickly improve on reporting and managing the pipeline.
    Last edited by avetis: 16/05/24
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.